{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021390565401472.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/ags3.12612"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/ags3.12612"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ags3.12612"}},{"identifier":{"@type":"PMID","@value":"36643372"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2024075683"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Current status of liver transplantation for <scp>non‐B non‐C</scp> liver cirrhosis and hepatocellular carcinoma"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title><jats:p>Recently, non‐B non‐C chronic liver diseases, including alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), have markedly increased worldwide. Liver transplantation (LT) is an effective curative therapy for hepatocellular carcinoma (HCC) as well as decompensated liver cirrhosis. In Japan, where the source of liver grafts is strongly dependent on living donors, efforts have been made to unify the indications for eligibility of HCC patients for LT, leading to the development of 5‐5‐500 criteria. Along with the expansion of eligibility for LT, the current changing trends in underlying liver diseases of LT recipients, which are related to the rising tide of non‐B non‐C cirrhosis and HCC, are highlighting the importance of peri‐transplant management of patients with various comorbidities. The post‐LT prognosis of patients with ALD is significantly affected by de novo malignancies and metabolic syndrome‐related complications as well as posttransplant alcohol relapse. NAFLD/NASH patients often suffer from obesity, type 2 diabetes mellitus, and other metabolic syndrome‐related disorders, and nonneoplastic factors such as cardiovascular events and recurrence of NAFLD/NASH have a significant impact on post‐LT outcomes. Patient management in the peri‐transplant period as well as risk assessment for LT are key to improving post‐LT outcomes in the era of a growing number of cases of LT for non‐B non‐C liver diseases.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420849299957830400","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"20899215"},{"@type":"NRID","@value":"1000020899215"}],"foaf:name":[{"@value":"Takahiro Nishio"}],"jpcoar:affiliationName":[{"@value":"Department of Surgery, Graduate School of Medicine Kyoto University  Kyoto Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390565401601","@type":"Researcher","foaf:name":[{"@value":"Takashi Ito"}],"jpcoar:affiliationName":[{"@value":"Department of Surgery, Graduate School of Medicine Kyoto University  Kyoto Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390565401602","@type":"Researcher","foaf:name":[{"@value":"Koichiro Hata"}],"jpcoar:affiliationName":[{"@value":"Department of Surgery, Graduate School of Medicine Kyoto University  Kyoto Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390565401600","@type":"Researcher","foaf:name":[{"@value":"Kojiro Taura"}],"jpcoar:affiliationName":[{"@value":"Department of Surgery, Graduate School of Medicine Kyoto University  Kyoto Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390565401472","@type":"Researcher","foaf:name":[{"@value":"Etsuro Hatano"}],"jpcoar:affiliationName":[{"@value":"Department of Surgery, Graduate School of Medicine Kyoto University  Kyoto Japan"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"24750328"},{"@type":"EISSN","@value":"24750328"}],"prism:publicationName":[{"@value":"Annals of Gastroenterological Surgery"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2022-08-23","prism:volume":"7","prism:number":"1","prism:startingPage":"42","prism:endingPage":"52"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["http://creativecommons.org/licenses/by/4.0/"],"url":[{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/ags3.12612"},{"@id":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ags3.12612"},{"@id":"https://search.jamas.or.jp/link/ui/2024075683"}],"createdAt":"2022-08-24","modifiedAt":"2023-08-19","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=nonalcoholic%20fatty%20liver%20disease","dc:title":"nonalcoholic fatty liver disease"},{"@id":"https://cir.nii.ac.jp/all?q=liver%20transplantation","dc:title":"liver transplantation"},{"@id":"https://cir.nii.ac.jp/all?q=RD1-811","dc:title":"RD1-811"},{"@id":"https://cir.nii.ac.jp/all?q=RC799-869","dc:title":"RC799-869"},{"@id":"https://cir.nii.ac.jp/all?q=Diseases%20of%20the%20digestive%20system.%20Gastroenterology","dc:title":"Diseases of the digestive system. Gastroenterology"},{"@id":"https://cir.nii.ac.jp/all?q=Surgery","dc:title":"Surgery"},{"@id":"https://cir.nii.ac.jp/all?q=nonalcoholic%20steatohepatitis","dc:title":"nonalcoholic steatohepatitis"},{"@id":"https://cir.nii.ac.jp/all?q=Review%20Articles","dc:title":"Review Articles"},{"@id":"https://cir.nii.ac.jp/all?q=non%E2%80%90B%20non%E2%80%90C%20hepatocellular%20carcinoma","dc:title":"non‐B non‐C hepatocellular carcinoma"},{"@id":"https://cir.nii.ac.jp/all?q=alcoholic%20liver%20disease","dc:title":"alcoholic liver disease"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040850857204926080","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21K16444"},{"@type":"JGN","@value":"JP21K16444"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K16444/"}],"notation":[{"@language":"ja","@value":"肝線維化における筋線維芽細胞と癌関連線維芽細胞の活性化機序の検証"},{"@language":"en","@value":"Molecular mechanism of activation of myofibroblasts and cancer associated fibroblasts in fibrotic liver"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050573243088385152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019"}]},{"@id":"https://cir.nii.ac.jp/crid/1050855224113500160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004230210854528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235524794496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235594039680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living‐related donor liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011143588931328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Incidence and risk factors for cancer after liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145254018304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"National Experience on Down‐Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha‐Fetoprotein, and Wait Time"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146290186624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013171295185792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013188478221568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: The Importance of a Washout Period"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013188570518144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pretransplant use of toripalimab for hepatocellular carcinoma resulting in fatal acute hepatic necrosis in the immediate postoperative period"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017286978903296","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706237687296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292618954524544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619927665152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621447277056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643826177536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294663735566208","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294663805889408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302869446095232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302869446245760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302869446271616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of diabetes mellitus in patients undergoing liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302869446478976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Keys to long-term care of the liver transplant recipient"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302869446663936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Orthotopic liver transplantation using low-dose tacrolimus and sirolimus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302869446848512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302869446875264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver transplantation for hepatocellular carcinoma: Management after the transplant"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302869446876800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302870943608320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567180129936000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185477949184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Significance of pretransplant abstinence on harmful alcohol relapse after liver transplantation for alcoholic cirrhosis in <scp>J</scp>apan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094256612864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094746846592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta-Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094893897728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095400396928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Use of Everolimus in Liver Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576120741998592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576120757240448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576121980101888","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576138156938240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"PD-1 inhibitor as bridge therapy to liver transplantation?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360583648410377984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345431571328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immunotherapy as a Downstaging Therapy for Liver Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345431580544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for Alcoholic Liver Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345431581312","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolic syndrome: Is immunosuppression to blame?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345432097280","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345432099328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NAFLD and liver transplantation: Disease burden, current management and future challenges"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345432729856","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Body Weight Parameters are Related to Morbidity and Mortality After Liver Transplantation: A Systematic Review and Meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345432805504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345433074304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584345433083776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346099074816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: Results of a controlled clinical trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346099076224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346100240000","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346100248576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346100250240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346100252288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Changing Trends in Liver Transplantation: Challenges and Solutions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346100504320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346100556928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584346100561408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656191872256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569866656896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570102923008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857595127014400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857595615214208","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epidemiology of Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865818722647680","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long‐term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865818722664320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term medical comorbidities and their management: Hypertension/cardiovascular disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865818723193344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NAFLD and liver transplantation: Current burden and expected challenges"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865818723377664","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865818723782656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Post-transplant Outcomes of Persons Receiving a Liver Graft for Alcoholic Liver Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865818723871872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Investigation of PNPLA3 and IL28B Genotypes on Diabetes and Obesity After Liver Transplantation: Insight Into Mechanisms of Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865818724223872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View"}]},{"@id":"https://cir.nii.ac.jp/crid/1360866730491746560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combination of risk alleles of <i>PNPLA3</i>, <i>TM6SF2</i>, and <i>HSD17B13</i> of donors can predict recurrence of steatotic liver disease after liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131420431898624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045375844480","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Recurrent Alcoholic Cirrhosis In Severe Alcoholic Relapse After Liver Transplantation: A Frequent and Serious Complication"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045695835264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Recurrence After Liver Transplantation for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046054301440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518517806848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"OPTN/SRTR 2017 Annual Data Report: Liver"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519894302336","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Living Donor Liver Transplantation for Patients with HCC Exceeding the Milan Criteria: A Proposal of Expanded Criteria"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520355326464","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Sirolimus-Based Immunosuppression in Liver Transplantation for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521106217600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694370691492864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expanded living‐donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5‐5‐500 rule ‐ a retrospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995724254208","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995927091328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Total tumor volume and alpha‐fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468843891328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469853213824","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"EASL Clinical Practice Guidelines: Liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470082920448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Posttransplant Malignancies in Solid Organ Adult Recipients"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894917466496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolic syndrome in liver transplantation: Relation to etiology and immunosuppression"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894961986688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895676897280","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Extending indication"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370684733568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370994410112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845621633792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845920625792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846276729344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846331543168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320814626432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670321102196736","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: Exploratory analysis from the UNOS database"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793175319680","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793673612288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epidemiology and surveillance for hepatocellular carcinoma: New trends"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794471999488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Patatin-Like Phospholipase Domain-Containing Protein 3 rs738409-G in Recipients of Liver Transplants Is a Risk Factor for Graft Steatosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795065245440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795857827072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268697539328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268886850688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233271101405056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Living Donor Liver Transplantation for Hepatocellular Carcinoma: Tokyo University Series"}]},{"@id":"https://cir.nii.ac.jp/crid/1370021390565401472","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cyclosporin versus tacrolimus for liver transplanted patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390853487385075840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Liver Transplantation in Japan—Registry by the Japanese Liver Transplantation Society—"},{"@language":"ja","@value":"肝移植症例登録報告"},{"@value":"Liver transplantation in Japan―registry by the Japanese liver transplantation society"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/ags3.12612"},{"@type":"KAKEN","@value":"PRODUCT-25057733"},{"@type":"OPENAIRE","@value":"doi_dedup___::c0e132f84192268e293abd1b1f314cfe"},{"@type":"CROSSREF","@value":"10.1111/hepr.14086_references_DOI_Xhbtghmwne6UfIoQ9mqu32HT3QL"}]}